Olivia Liu, Philip Y Sun, Syed A Ahmad, Andrew Kalra, Amy Feng, Glenn J R Whitman, Bo Soo Kim, Sung-Min Cho
{"title":"Characteristics and risk factors of delirium in patients on veno-arterial extracorporeal membrane oxygenation.","authors":"Olivia Liu, Philip Y Sun, Syed A Ahmad, Andrew Kalra, Amy Feng, Glenn J R Whitman, Bo Soo Kim, Sung-Min Cho","doi":"10.1177/02676591251319684","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Sparse data exist on delirium in VA-ECMO. We aim to describe the characteristics, risk factors, and outcomes of delirium in VA-ECMO.</p><p><strong>Methods: </strong>We retrospectively reviewed adults's electronic medical records on VA-ECMO in our ECMO registry in 2016-2022. Delirium was assessed by the Confusion Assessment Method for the intensive care unit when patients scored -3 or above on the Richmond Agitation-Sedation Scale. The primary outcomes were delirium prevalence and the proportion of delirium-present days while on VA-ECMO support. Multivariable logistic regression was used to evaluate delirium risk factors.</p><p><strong>Results: </strong>Of 208 patients (median [interquartile range] age: 53 [40-62]), 138 (66.3%) had delirium during ECMO. Delirium occurred on day 2.5 [1.0-7.0] of ECMO and was detected in 42% [20%-66%] of ECMO days. There were no differences in acute brain injury (24% vs 33%, <i>p</i> = .34) between patients with and without delirium. Survival analysis showed no significant association between delirium and 30-day mortality (<i>p</i> = .24). In multivariable analysis, ECMO day 1 arterial carbon dioxide partial pressure (adjusted odds ratio [aOR] = 1.29; 95% CI = 1.03-1.73), number of sedatives (aOR = 2.67; 95% CI = 1.68-2.95), and African American race/ethnicity (aOR = 16.45; 95% CI = 9.65-22.51) were associated with delirium.</p><p><strong>Conclusions: </strong>Delirium was present in 66.3% of VA-ECMO patients and was detected early during ECMO. Modifiable risk factors included multiple sedative agents and early hypercapnia. Delirium did not increase risk for mortality.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591251319684"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perfusion-Uk","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02676591251319684","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Sparse data exist on delirium in VA-ECMO. We aim to describe the characteristics, risk factors, and outcomes of delirium in VA-ECMO.
Methods: We retrospectively reviewed adults's electronic medical records on VA-ECMO in our ECMO registry in 2016-2022. Delirium was assessed by the Confusion Assessment Method for the intensive care unit when patients scored -3 or above on the Richmond Agitation-Sedation Scale. The primary outcomes were delirium prevalence and the proportion of delirium-present days while on VA-ECMO support. Multivariable logistic regression was used to evaluate delirium risk factors.
Results: Of 208 patients (median [interquartile range] age: 53 [40-62]), 138 (66.3%) had delirium during ECMO. Delirium occurred on day 2.5 [1.0-7.0] of ECMO and was detected in 42% [20%-66%] of ECMO days. There were no differences in acute brain injury (24% vs 33%, p = .34) between patients with and without delirium. Survival analysis showed no significant association between delirium and 30-day mortality (p = .24). In multivariable analysis, ECMO day 1 arterial carbon dioxide partial pressure (adjusted odds ratio [aOR] = 1.29; 95% CI = 1.03-1.73), number of sedatives (aOR = 2.67; 95% CI = 1.68-2.95), and African American race/ethnicity (aOR = 16.45; 95% CI = 9.65-22.51) were associated with delirium.
Conclusions: Delirium was present in 66.3% of VA-ECMO patients and was detected early during ECMO. Modifiable risk factors included multiple sedative agents and early hypercapnia. Delirium did not increase risk for mortality.
目的:关于VA-ECMO患者谵妄的资料较少。我们的目的是描述VA-ECMO中谵妄的特征、危险因素和结果。方法:我们回顾性地回顾了2016-2022年ECMO登记处成人VA-ECMO电子病历。当患者在Richmond激动-镇静量表中得分为-3或以上时,采用重症监护病房的混淆评估法评估谵妄。主要结局是在VA-ECMO支持下谵妄患病率和谵妄出现天数的比例。采用多变量logistic回归评价谵妄危险因素。结果:208例患者(年龄中位数:53岁[40-62岁])中,138例(66.3%)在ECMO期间出现谵妄。谵妄发生在ECMO的第2.5天[1.0-7.0],在ECMO的42%[20%-66%]天中被检测到。谵妄患者与非谵妄患者急性脑损伤发生率无差异(24% vs 33%, p = 0.34)。生存分析显示谵妄与30天死亡率无显著相关性(p = 0.24)。在多变量分析中,ECMO第1天动脉二氧化碳分压(调整优势比[aOR] = 1.29;95% CI = 1.03-1.73),镇静药数量(aOR = 2.67;95% CI = 1.68-2.95),非裔美国人种族/族裔(aOR = 16.45;95% CI = 9.65-22.51)与谵妄相关。结论:66.3%的VA-ECMO患者存在谵妄,并在ECMO早期被发现。可改变的危险因素包括多种镇静剂和早期高碳酸血症。谵妄不增加死亡风险。
期刊介绍:
Perfusion is an ISI-ranked, peer-reviewed scholarly journal, which provides current information on all aspects of perfusion, oxygenation and biocompatibility and their use in modern cardiac surgery. The journal is at the forefront of international research and development and presents an appropriately multidisciplinary approach to perfusion science.